Lu; Jian-Feng
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lu; Jian-Feng.The latest application filed is for "novel angiopoietin 2, vegf dual antagonists".
- Lu; Jian-Feng - Oak Park CA
- Lu; Jian-Feng - Foster City CA US
| Patent | Date |
|---|---|
| Novel Angiopoietin 2, Vegf Dual Antagonists App 20220041705 - Lu; Yuefeng ; et al. | 2022-02-10 |
| Novel Cytokine Prodrugs App 20210260163 - YU; Chunxiao ; et al. | 2021-08-26 |
| Angiopoietin 2, VEGF dual antagonists Grant 11,059,885 - Lu , et al. July 13, 2 | 2021-07-13 |
| Novel Il-15 Prodrugs And Methods Of Use Thereof App 20200392235 - LU; Yuefeng ; et al. | 2020-12-17 |
| Fixed Dosing Of Her Antibodies App 20200239595 - ALLISON; DAVID E. ; et al. | 2020-07-30 |
| Angiopoietin 2, VEGF dual antagonists Grant 10,654,922 - Lu , et al. | 2020-05-19 |
| Novel Angiopoietin 2, VEGF Dual Antagonists App 20200131260 - Lu; Yuefeng ; et al. | 2020-04-30 |
| Novel Angiopoietin 2, Vegf Dual Antagonists App 20200102381 - Lu; Yuefeng ; et al. | 2020-04-02 |
| Novel Antibodies And Methods For Making And Using The Same App 20200040101 - Lu; Yuefeng ; et al. | 2020-02-06 |
| Novel Feline Erythropoietin Receptor Agonists App 20190248858 - Lu; Jian-Feng ; et al. | 2019-08-15 |
| Feline erythropoietin receptor agonists Grant 10,287,336 - Lu , et al. | 2019-05-14 |
| PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis App 20190106494 - Wang; Aijun ; et al. | 2019-04-11 |
| Fixed Dosing Of Her Antibodies App 20180327510 - ALLISON; DAVID E. ; et al. | 2018-11-15 |
| PD-L1 specific monoclonal antibodies for disease treatment and diagnosis Grant 10,077,308 - Wang , et al. September 18, 2 | 2018-09-18 |
| Novel Antibody-albumin-drug Conjugates (aadc) And Methods For Using Them App 20180055944 - Lu; Yuefeng ; et al. | 2018-03-01 |
| PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis App 20170355770 - Wang; Aijun ; et al. | 2017-12-14 |
| Novel Angiopoietin 2, VEGF Dual Antagonists App 20170327569 - Lu; Yuefeng ; et al. | 2017-11-16 |
| Fixed Dosing Of Her Antibodies App 20170037147 - Allison; David E. ; et al. | 2017-02-09 |
| Fusion Proteins With Dual Receptor Agonist Activities App 20160137712 - Lu; Yuefeng ; et al. | 2016-05-19 |
| Novel Feline Erythropoietin Receptor Agonists App 20160083444 - Lu; Jian-Feng ; et al. | 2016-03-24 |
| Fixed Dosing Of Her Antibodies App 20150093381 - Allison; David E. ; et al. | 2015-04-02 |
| Methods And Compositions Relating To Inhibition Of Igf-1r App 20140037642 - McCaffery; Ian ; et al. | 2014-02-06 |
| Fixed Dosing Of Her Antibodies App 20130142865 - Allison; David E. ; et al. | 2013-06-06 |
| Fixed dosing of HER antibodies Grant 8,404,234 - Allison , et al. March 26, 2 | 2013-03-26 |
| Fixed Dosing Of Her Antibodies App 20090081223 - Allison; David E. ; et al. | 2009-03-26 |
| Fixed dosing of HER antibodies Grant 7,449,184 - Allison , et al. November 11, 2 | 2008-11-11 |
| Fixed dosing of HER antibodies App 20060165702 - Allison; David E. ; et al. | 2006-07-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 